Cargando…

External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study

BACKGROUND: External quality assurance (EQA) systems are essential to ensure accurate diagnosis of TB and drug-resistant TB. The implementation of EQA through organising regular EQA rounds and identification of training needs is one of the key activities of the European TB reference laboratory netwo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikolayevskyy, Vladyslav, Hillemann, Doris, Richter, Elvira, Ahmed, Nada, van der Werf, Marieke J., Kodmon, Csaba, Drobniewski, Francis, Ruesch-Gerdes, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824391/ https://www.ncbi.nlm.nih.gov/pubmed/27055064 http://dx.doi.org/10.1371/journal.pone.0152926

Ejemplares similares

European Union training programme for tuberculosis laboratory experts: design, contribution and future direction
por: Raftery, Philomena, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2021)

Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?
por: Merk, Hanna, et al.
Publicado: (2019)

Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs
por: Farooq, Hamzah Z., et al.
Publicado: (2021)

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union
por: van der Werf, Marieke J., et al.
Publicado: (2017)

Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021
por: Cristea, Veronica, et al.
Publicado: (2023)

Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015
por: Ködmön, Csaba, et al.
Publicado: (2017)

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area
por: Anthony, R. M., et al.
Publicado: (2022)

First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries
por: Hillemann, Doris, et al.
Publicado: (2013)

Inventory study of non-tuberculous mycobacteria in the European Union
por: van der Werf, Marieke J, et al.
Publicado: (2014)

Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study
por: Mathys, V., et al.
Publicado: (2018)

MIRU-VNTR Genotyping of Mycobacterium tuberculosis Strains Using QIAxcel Technology: A Multicentre Evaluation Study
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2016)

False-positive COVID-19 results: hidden problems and costs
por: Surkova, Elena, et al.
Publicado: (2020)

Tuberculosis treatment outcome monitoring in European Union countries: systematic review
por: van Hest, Rob, et al.
Publicado: (2013)

Mykobakterien, nichttuberkulöse (NTM)
por: Rüsch-Gerdes, Sabine, et al.
Publicado: (2009)

Whole-Genome Sequencing as Tool for Investigating International Tuberculosis Outbreaks: A Systematic Review
por: van der Werf, Marieke J., et al.
Publicado: (2019)

Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries
por: Andrés, Marta, et al.
Publicado: (2019)

Associations between Mycobacterium tuberculosis Strains and Phenotypes
por: Brown, Timothy, et al.
Publicado: (2010)

Discriminatory Ability of Hypervariable Variable Number Tandem Repeat Loci in Population-based Analysis of Mycobacterium tuberculosis Strains, London, UK
por: Velji, Preya, et al.
Publicado: (2009)

Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014
por: Sotgiu, Giovanni, et al.
Publicado: (2017)

Is tuberculosis crossing borders at the Eastern boundary of the European Union?
por: van der Werf, Marieke J., et al.
Publicado: (2013)

Completeness of tuberculosis (TB) notification: inventory studies and capture-recapture analyses, six European Union countries, 2014 to 2016
por: Straetemans, Masja, et al.
Publicado: (2020)

Rates of Latent Tuberculosis in Health Care Staff in Russia
por: Drobniewski, Francis, et al.
Publicado: (2007)

Performance of the Genotype(® )MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2009)

Differentiation of Tuberculosis Strains in a Population with Mainly Beijing-family Strains
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2006)

Current state of national TB laboratory networks in Europe: achievements and challenges
por: Klaos, K., et al.
Publicado: (2022)

Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation
por: Drobniewski, Francis, et al.
Publicado: (2013)

Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017–2019: an ECDC pilot study
por: Tagliani, Elisa, et al.
Publicado: (2021)

Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study
por: Balabanova, Yanina, et al.
Publicado: (2011)

Identifying components for programmatic latent tuberculosis infection control in the European Union
por: Sandgren, Andreas, et al.
Publicado: (2016)

Will the European Union reach the United Nations Millennium declaration target of a 50% reduction of tuberculosis mortality between 1990 and 2015?
por: van der Werf, Marieke J., et al.
Publicado: (2017)

Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles
por: van der Werf, Marieke J., et al.
Publicado: (2016)

COPD care delivery pathways in five European Union countries: mapping and health care professionals’ perceptions
por: Kayyali, Reem, et al.
Publicado: (2016)

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014
por: Karo, Basel, et al.
Publicado: (2019)

The European Health Union and the protection of public health in the European Union: Is the European Union prepared for future cross-border health threats?
por: Seitz, Claudia
Publicado: (2023)

The European Union and the Regions /
Publicado: (1995)

Economic burden of work injuries and diseases: a framework and application in five European Union countries
por: Tompa, Emile, et al.
Publicado: (2021)

TB management in the European Union/European Economic Area: a multi-centre survey
por: Sotgiu, G., et al.
Publicado: (2021)

Association analysis of the LTA4H gene polymorphisms and pulmonary tuberculosis in 9115 subjects
por: Curtis, James, et al.
Publicado: (2011)

Report on the state of the European Union /
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_g71nj3laucvmcmsrul498p2mne